FindTrial
Sign In

Study for optimalization of protocol in the treatment of ''Shen-Xu-Tan-Shi'' type polycystic ovary syndrome induced infertility

Study for optimalization of protocol in the treatment of ''Shen-Xu-Tan-Shi'' type polycystic ovary syndrome induced infertility

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003271
Enrollment
Unknown
Registered
2020-05-03
Start date
2020-05-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility with polycystic ovary syndrome

Interventions

Experimental group:''Bu-Shen Hua-tan'' Chinese medicine
Control group:Placebo

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: All cases must meet the diagnostic criteria of infertility, PCOS and kidney deficiency, phlegm and dampness.Ages 20-45.

Exclusion criteria

Exclusion criteria: 1. allergy to experimental or known drug ingredients; 2. accompanied by liver and kidney function insufficiency or other viscera disease; 3. patients participating in other clinical trials; 4. the researchers believe that other reasons are not suitable for clinical subjects.

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate;—

Secondary

MeasureTime frame
Letrozole dosage;WHR;Number of ovulation cycles;Signs and symptoms;BMI;—

Countries

China

Contacts

Public ContactCheng Wen

Shanghai changhai hospital

chengwen1014@qq.com+86 18917258017

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026